City of Hope Reveals Vision for World-Class Cancer Care in Orange County

June 25, 2019 | City of Hope

City of Hope has accelerated its plans for a $1 billion comprehensive cancer campus in Orange County, bringing highly specialized cancer care, clinical trials, precision medicine and early detection to the nation’s sixth most populous county.

Continue Reading

CAR T researcher Saul Priceman wants to teach your body to fight cancer

September 13, 2018 | Letisia Marquez

Since 2013, City of Hope researcher Saul Priceman, Ph.D., and his team have developed one of most comprehensive CAR T programs in the nation.

CAR T Laboratory Research Yields Promising Prostate Cancer Results

April 17, 2018 | Letisia Marquez

City of Hope physicians have successfully treated blood cancers with chimeric antigen receptor (CAR) T cell therapy, and they are working to expand that therapy to patients with prostate cancer and other solid tumors.

With New CAR T Approach, City of Hope CEACAM Research Comes Full Circle

February 9, 2018 | Jyoti Madhusoodanan

CEA remains one of the most widely used clinical markers of cancer. As the diverse roles of CEA and CEACAMs, have grown clearer, researchers at City of Hope are working on a new wave of clinical tools and therapies.

New Target for Prostate Cancer Treatment and Prevention Identified

March 29, 2017 | Katie Neith

While prostate cancer is often treated successfully, it is still the third leading cancer killer among men and represents a huge health and economic burden. Now, a team from City of Hope believes they have found a key mechanism for potentially keeping the disease at bay, both before and after diagnosis.

Beating prostate cancer: ‘We’re taking off the brakes’

March 24, 2016 | City of Hope

Researchers at City of Hope believe they are on the verge of significant headway in the treatment of advanced prostate cancer, thanks to new thinking and “staggering” early success.